Robot-Assisted Endoscopes

Global Robot-Assisted Endoscopes Market to Reach US$2.5 Billion by 2030

The global market for Robot-Assisted Endoscopes estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Outpatient Facilities segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$412.0 Million While China is Forecast to Grow at 7.7% CAGR

The Robot-Assisted Endoscopes market in the U.S. is estimated at US$412.0 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$396.6 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.5% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Global Robot-Assisted Endoscope Market - Key Trends & Drivers Summarized

How Are Robotics Transforming Endoscopic Procedures?

The integration of robotics into endoscopy is revolutionizing minimally invasive diagnostics and therapeutic procedures, offering enhanced precision, flexibility, and control compared to conventional manual techniques. Robot-assisted endoscopy is particularly beneficial in complex procedures such as gastrointestinal (GI) endoscopy, bronchoscopy, and neurosurgical endoscopy, where precision is critical. Robotic systems provide superior maneuverability through articulating arms and AI-powered navigation, enabling surgeons to access hard-to-reach areas with greater ease. Haptic feedback mechanisms are further improving the accuracy and safety of endoscopic interventions. Additionally, remote-controlled robotic endoscopy is reducing the need for direct operator involvement, enabling enhanced patient safety during infectious disease outbreaks. With ongoing advancements in real-time imaging, machine learning, and AI-guided decision-making, robot-assisted endoscopy is poised to become the gold standard in endoscopic diagnostics and surgery.

What Are The Key Applications Driving Adoption?

Robot-assisted endoscopy is finding widespread adoption across multiple medical disciplines, with gastroenterology, pulmonology, and oncology being the leading fields of application. In GI endoscopy, robotic systems are being used for advanced diagnostics and minimally invasive procedures such as polypectomy, biopsy, and tumor ablation. Robotic bronchoscopy is also gaining traction, enabling the precise navigation of lung airways for early-stage cancer detection and targeted biopsy collection. Neurosurgery is another emerging area where robot-assisted neuro-endoscopy is improving surgical access to deep-seated brain lesions while minimizing trauma. Additionally, urological and gynecological robotic endoscopic procedures are seeing increasing adoption, as they offer enhanced precision in delicate surgeries. As healthcare providers strive to improve patient outcomes, the demand for robotic-assisted endoscopic solutions is rapidly growing.

How Are AI and Machine Learning Enhancing Robotic Endoscopy?

The integration of AI and machine learning (ML) in robotic-assisted endoscopy is revolutionizing procedural efficiency, image interpretation, and decision-making. AI-powered image enhancement is improving real-time visualization, enabling better lesion detection and classification in GI and pulmonary procedures. Machine learning algorithms are assisting in automated polyp detection, anomaly recognition, and real-time biopsy guidance, reducing human error and improving diagnostic accuracy. Additionally, AI-driven motion control and autonomous navigation are optimizing robotic movements, enhancing precision, and reducing procedural time. Remote AI-assisted endoscopy platforms are also gaining momentum, enabling expert consultations and robotic-assisted interventions from remote locations. These technological advancements are making robot-assisted endoscopy smarter, more efficient, and increasingly indispensable in modern healthcare settings.

What Factors Are Driving Growth in the Robot-Assisted Endoscope Market?

The growth in the robot-assisted endoscope market is driven by several factors, including the increasing prevalence of gastrointestinal and pulmonary diseases, rising adoption of minimally invasive procedures, and advancements in AI-powered robotic technologies. The demand for early cancer detection and precision biopsy techniques is fueling the adoption of robotic bronchoscopy and GI endoscopy. The expansion of telemedicine and remote surgical assistance is also playing a significant role in the market’s evolution. Additionally, the growing focus on reducing procedural complications, improving patient outcomes, and enhancing surgical efficiency is prompting healthcare facilities to invest in robotic-assisted endoscopic platforms. As regulatory approvals increase and research into next-generation robotic endoscopy systems accelerates, the market is expected to witness substantial growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Robot-Assisted Endoscopes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
End-Use (Hospitals, Outpatient Facilities)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

• Ambu A/S
• Arthrex, Inc.
• Asensus Surgical US, Inc.
• Auris Health, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Brainlab AG
• CapsoVision, Inc.
• Carl Zeiss AG
• CMR Surgical Ltd.
• ConMed Corporation
• Cook Medical
• EndoQuest Robotics
• Fortimedix Surgical B.V.
• Fujifilm Holdings Corporation
• HOYA Corporation
• Intuitive Surgical
• Johnson & Johnson Services, Inc.
• KARL STORZ SE & Co. KG
• Laborie Medical Technologies Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.